<VariationArchive VariationID="2921941" VariationName="NM_012414.4(RAB3GAP2):c.340del (p.Met114fs)" VariationType="Deletion" Accession="VCV002921941" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3085432" VariationID="2921941">
      <GeneList>
        <Gene Symbol="RAB3GAP2" FullName="RAB3 GTPase activating non-catalytic protein subunit 2" GeneID="25782" HGNC_ID="HGNC:17168" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q41</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="220148293" stop="220272453" display_start="220148293" display_stop="220272453" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="220321609" stop="220445842" display_start="220321609" display_stop="220445842" Strand="-" />
          </Location>
          <OMIM>609275</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_012414.4(RAB3GAP2):c.340del (p.Met114fs)</Name>
      <CanonicalSPDI>NC_000001.11:220212932:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q41</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="220212933" stop="220212933" display_start="220212933" display_stop="220212933" variantLength="1" positionVCF="220212932" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="220386275" stop="220386275" display_start="220386275" display_stop="220386275" variantLength="1" positionVCF="220386274" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>M114fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.220212935del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.220212935del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012414.4" sequenceAccession="NM_012414" sequenceVersion="4" change="c.340del" MANESelect="true">
            <Expression>NM_012414.4:c.340del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036546.2" sequenceAccession="NP_036546" sequenceVersion="2" change="p.Met114fs">
            <Expression>NP_036546.2:p.Met114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.220386277del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.220386277del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015837.2" sequenceAccession="NG_015837" sequenceVersion="2" change="g.64569del">
            <Expression>NG_015837.2:g.64569del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_012414.4(RAB3GAP2):c.340del (p.Met114fs) AND multiple conditions" Accession="RCV003782963" Version="1">
        <ClassifiedConditionList TraitSetID="13612">
          <ClassifiedCondition DB="MedGen" ID="C0796037">Martsolf syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3280214">Warburg micro syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23420520</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13612" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16545" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MICRO SYNDROME 2</ElementValue>
                <XRef Type="MIM" ID="614225" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Warburg micro syndrome 2</ElementValue>
                <XRef ID="MONDO:0013641" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WARBM2</ElementValue>
                <XRef Type="MIM" ID="614225" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">RAB18 deficiency is the molecular deficit underlying both Warburg micro syndrome (characterized by eye, nervous system, and endocrine abnormalities) and Martsolf syndrome (characterized by similar – but milder – findings). To date Warburg micro syndrome comprises &gt;96% of reported individuals with genetically defined RAB18 deficiency. The hallmark ophthalmologic findings are bilateral congenital cataracts, usually accompanied by microphthalmia, microcornea (diameter &lt;10), and small atonic pupils. Poor vision despite early cataract surgery likely results from progressive optic atrophy and cortical visual impairment. Individuals with Warburg micro syndrome have severe to profound intellectual disability (ID); those with Martsolf syndrome have mild to moderate ID. Some individuals with RAB18 deficiency also have epilepsy. In Warburg micro syndrome, a progressive ascending spastic paraplegia typically begins with spastic diplegia and contractures during the first year, followed by upper-limb involvement leading to spastic quadriplegia after about age five years, often eventually causing breathing difficulties. In Martsolf syndrome infantile hypotonia is followed primarily by slowly progressive lower-limb spasticity. Hypogonadism – when present – manifests in both syndromes, in males as micropenis and/or cryptorchidism and in females as hypoplastic labia minora, clitoral hypoplasia, and small introitus.</Attribute>
                <XRef ID="NBK475670" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15780" />
                <XRef ID="15780" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29300443</ID>
                <ID Source="BookShelf">NBK475670</ID>
              </Citation>
              <XRef ID="2510" DB="Orphanet" />
              <XRef ID="C3280214" DB="MedGen" />
              <XRef ID="MONDO:0013641" DB="MONDO" />
              <XRef Type="MIM" ID="614225" DB="OMIM" />
            </Trait>
            <Trait ID="5455" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Martsolf syndrome</ElementValue>
                <XRef ID="MONDO:0023910" DB="MONDO" />
                <XRef ID="722380003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cataract mental retardation hypogonadism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital cataract with intellectual disability and hypogonadotropic hypogonadism syndrome</ElementValue>
                <XRef ID="722380003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MARTS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">RAB18 deficiency is the molecular deficit underlying both Warburg micro syndrome (characterized by eye, nervous system, and endocrine abnormalities) and Martsolf syndrome (characterized by similar – but milder – findings). To date Warburg micro syndrome comprises &gt;96% of reported individuals with genetically defined RAB18 deficiency. The hallmark ophthalmologic findings are bilateral congenital cataracts, usually accompanied by microphthalmia, microcornea (diameter &lt;10), and small atonic pupils. Poor vision despite early cataract surgery likely results from progressive optic atrophy and cortical visual impairment. Individuals with Warburg micro syndrome have severe to profound intellectual disability (ID); those with Martsolf syndrome have mild to moderate ID. Some individuals with RAB18 deficiency also have epilepsy. In Warburg micro syndrome, a progressive ascending spastic paraplegia typically begins with spastic diplegia and contractures during the first year, followed by upper-limb involvement leading to spastic quadriplegia after about age five years, often eventually causing breathing difficulties. In Martsolf syndrome infantile hypotonia is followed primarily by slowly progressive lower-limb spasticity. Hypogonadism – when present – manifests in both syndromes, in males as micropenis and/or cryptorchidism and in females as hypoplastic labia minora, clitoral hypoplasia, and small introitus.</Attribute>
                <XRef ID="NBK475670" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3406" />
                <XRef ID="3406" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29300443</ID>
                <ID Source="BookShelf">NBK475670</ID>
              </Citation>
              <XRef ID="1387" DB="Orphanet" />
              <XRef ID="C0796037" DB="MedGen" />
              <XRef ID="MONDO:0023910" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS212720" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8559260" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="30937320|MedGen:C0796037;C3280214" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004603247" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23420520</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Met114Cysfs*11) in the RAB3GAP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAB3GAP2 are known to be pathogenic (PMID: 23420520). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RAB3GAP2-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAB3GAP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.220386275del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796037" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280214" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8559260" TraitType="Disease" MappingType="XRef" MappingValue="C3280214" MappingRef="MedGen">
        <MedGen CUI="C3280214" Name="Warburg micro syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8559260" TraitType="Disease" MappingType="XRef" MappingValue="C0796037" MappingRef="MedGen">
        <MedGen CUI="C0796037" Name="Martsolf syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

